Inhibition of diacylglycerol kinase α restores restimulation-induced cell death and reduces immunopathology in XLP-1.

Science Translational Medicine
Elisa RuffoAndrea Graziani

Abstract

X-linked lymphoproliferative disease (XLP-1) is an often-fatal primary immunodeficiency associated with the exuberant expansion of activated CD8(+) T cells after Epstein-Barr virus (EBV) infection. XLP-1 is caused by defects in signaling lymphocytic activation molecule (SLAM)-associated protein (SAP), an adaptor protein that modulates T cell receptor (TCR)-induced signaling. SAP-deficient T cells exhibit impaired TCR restimulation-induced cell death (RICD) and diminished TCR-induced inhibition of diacylglycerol kinase α (DGKα), leading to increased diacylglycerol metabolism and decreased signaling through Ras and PKCθ (protein kinase Cθ). We show that down-regulation of DGKα activity in SAP-deficient T cells restores diacylglycerol signaling at the immune synapse and rescues RICD via induction of the proapoptotic proteins NUR77 and NOR1. Pharmacological inhibition of DGKα prevents the excessive CD8(+) T cell expansion and interferon-γ production that occur in SAP-deficient mice after lymphocytic choriomeningitis virus infection without impairing lytic activity. Collectively, these data highlight DGKα as a viable therapeutic target to reverse the life-threatening EBV-associated immunopathology that occurs in XLP-1 patients.

References

Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·K E NicholsD A Haber
Apr 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L M ShlapatskaS P Sidorenko
Jun 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·M J CzarP L Schwartzberg
Jan 25, 2003·Nature Cell Biology·Betty ChanMichael J Eck
Apr 3, 2003·Immunological Reviews·Amnon Altman, Martin Villalba
Jul 29, 2003·Nature Immunology·Xiao-Ping ZhongGary A Koretzky
Nov 13, 2004·Immunity·Jennifer L CannonsPamela L Schwartzberg
May 23, 2006·Immunity·Martin SpitalerDoreen Cantrell
Oct 10, 2006·Nature Immunology·Benjamin A OlenchockXiao-Ping Zhong
Dec 5, 2006·Biochemical Pharmacology·Cécile SpringaelOlivier Vosters
Dec 22, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Santhakumar Manicassamy, Zuoming Sun
Aug 8, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Selene Nunez-CruzKim E Nichols
Aug 14, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aibo WangBarbara A Osborne
Feb 5, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mariana I ChuckWeiguo Zhang
Jul 20, 2010·Immunological Reviews·Andrew L SnowMichael J Lenardo
Jul 28, 2010·Blood·Alexandra H FilipovichRebecca A Marsh
May 24, 2011·Nature Immunology·Emily J QuannMorgan Huse
May 25, 2011·The Journal of Experimental Medicine·Amy E MoranKristin A Hogquist
Sep 23, 2011·Molecular Biology of the Cell·Severine I GharbiIsabel Mérida
Nov 4, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gianluca BaldanziAndrea Graziani
Apr 2, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gil KatzAndrew L Snow
Aug 3, 2014·Journal of Clinical Immunology·Stuart G Tangye

❮ Previous
Next ❯

Citations

Nov 2, 2016·Frontiers in Cell and Developmental Biology·Matthew J RieseSteven M Albelda
Oct 13, 2016·Journal of Cellular Physiology·Alessandro PoliMatilde Y Follo
Nov 18, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sasha E LarsenAndrew L Snow
Oct 30, 2019·Cellular & Molecular Immunology·Kelsey VossAndrew L Snow
Jul 2, 2020·Clinical Science·Gianluca BaldanziMario Malerba
Apr 20, 2018·Frontiers in Immunology·Neelam PanchalPamela L Schwartzberg
Nov 7, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Suresh VelnatiGianluca Baldanzi
Nov 27, 2019·International Journal of Molecular Sciences·Gianluca Baldanzi, Mario Malerba
Nov 29, 2016·Frontiers in Cell and Developmental Biology·Shelley S ChenXiao-Ping Zhong
Dec 15, 2016·Frontiers in Cell and Developmental Biology·Gianluca BaldanziAndrea Graziani
Nov 5, 2019·Frontiers in Molecular Biosciences·Kelsey VossAndrew L Snow
Feb 6, 2020·Frontiers in Immunology·Jialong YangXiao-Ping Zhong
Jan 6, 2019·European Journal of Medicinal Chemistry·Suresh VelnatiGianluca Baldanzi
Apr 11, 2021·Cancer Immunology, Immunotherapy : CII·Javier Arranz-NicolásIsabel Merida
Jun 3, 2021·International Journal of Molecular Sciences·Suresh VelnatiGianluca Baldanzi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.